Lessee, Operating Lease, Liability, to be Paid of LakeShore Biopharma Co., Ltd. from 31 Mar 2023 to 31 Mar 2025

Taxonomy & unit: us-gaap: USD and CNY
Description: Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary: LakeShore Biopharma Co., Ltd. quarterly Lessee, Operating Lease, Liability, to be Paid in USD history and change rate from 31 Mar 2023 to 31 Mar 2025.
LakeShore Biopharma Co., Ltd. Lessee, Operating Lease, Liability, to be Paid for the quarter ending 31 Mar 2025 was $65,521, a 94% decline year-over-year.
LakeShore Biopharma Co., Ltd. quarterly Lessee, Operating Lease, Liability, to be Paid in CNY history and change rate from 31 Mar 2023 to 31 Mar 2025.
LakeShore Biopharma Co., Ltd. Lessee, Operating Lease, Liability, to be Paid for the quarter ending 31 Mar 2025 was ¥470,319, a 93% decline year-over-year.
Source SEC data: View on sec.gov

Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)

Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Change (%)

Lessee, Operating Lease, Liability, to be Paid, Quarterly (CNY)

Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Change (%)

LakeShore Biopharma Co., Ltd. Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025	$65,521	-$949,267	-94%	31 Mar 2025	20-F	31 Jul 2025	2025	FY
Q1 2024	$1,014,788	-$694,556	-41%	31 Mar 2024	20-F	15 Aug 2024	2024	FY
Q1 2023	$1,709,344			31 Mar 2023	20-F	26 Jul 2023	2023	FY

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025	¥470,319	-¥6,729,603	-93%	31 Mar 2025	20-F	31 Jul 2025	2025	FY
Q1 2024	¥7,199,922	-¥4,546,176	-39%	31 Mar 2024	20-F	15 Aug 2024	2024	FY
Q1 2023	¥11,746,098			31 Mar 2023	20-F	26 Jul 2023	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.